Metabolic score for insulin resistance predicts major adverse cardiovascular event in premature coronary artery disease

Abstract

METS-IR serves as a reliable prognostic predictor of MACE in patients with premature CAD. Therefore, METS-IR may be considered a novel, cost-effective, and dependable indicator for risk stratification and early intervention in premature CAD.